Patent 7229621 was granted and assigned to Torrey Pines Institute for Molecular Studies on June, 2007 by the United States Patent and Trademark Office.
The present invention is related to a method for enhancing the immunogenicity of an antigen in a mammal by introducing into the mammal an antigen or a portion thereof and administering to the mammal a treatment that increases antigen presentation in a lymphoid organ.